COVID-19 : Lets Collaborate
At Credence Genomics we want to collaborate with healthcare organizations, frontline healthcare personnel, researchers and anyone else with our skills during the pandemic. Virfast has been designed to identify all accessions up to date for SARS-CoV-2.Read more…
Our top priority
Patients and clinicians will benefit from variant data linked to clinical information. At Credence using the latest accessions uses bioinformatic analysis and machine learning to enhance testing data to effectively fight the pandemic
- Biweekly updates of accessions hence up to date mutational analysis
- Bioinformatic analysis and machine learning integration from multiple data points
- Active patient management based on data and comparative analysis
- Informative in patient triage
- Informative in resource and epidemiological management
Tests we offer
Our pan viral test examine reviews multiple viruses, and their reference strains through detailed analysis. Machine learning data points are integrated from real time clinical feedback and literature review. Along with identification of SARS-CoV-2 strains, Credence evaluates the complete virome of the sample. The product can be integrated with Credence’s other infectious disease products in cases of active sepsis
Key points
- Catering to real time accession updates as accessions are uploaded
- Data points and information benefits patients, clinicians, epidemiologists and government
- NGS data has the highest sensitivity and specificity
- Can be deployed on any site and any platform with Virfast
- Comprehensive infection control
Did you know?
With a team of experienced scientists, bioinformaticians, & infectious disease specialists work round the clock to offer high quality services. Every analysis and report is evaluated by a multi-disciplinary team
